Showing results (91-100 of 406) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1992
Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiencyR Hirschhorn, M N Nicknam, F Eng, et al.
The Journal of Clinical Investigation|September 1, 1986
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cellsB N Cronstein, R I Levin, J Belanoff, et al.
BMJ Sexual & Reproductive Health|October 30, 2020
Get PrEPPT (pre-exposure prophylaxis and pregnancy termination): an exploration of the values, attitudes and preferences regarding HIV and PrEP among women seeking abortionJessika Ann Ralph, Chen Yeh, Allison Cowett, et al.
BMC Pregnancy and Childbirth|November 15, 2015
Demand-side interventions for maternal care: evidence of more use, not better outcomesTaylor E Hurst, Katherine Semrau, Manasa Patna, et al.
International Journal for Equity in Health|October 2, 2020
Using implementation science to mitigate worsening health inequities in the United States during the COVID-19 pandemicTyler A Jacobson, Lauren E Smith, Lisa R Hirschhorn, et al.
The Journal of Clinical Investigation|October 1, 1979
Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzymeR Hirschhorn, V Roegner, T Jenkins, et al.
The New England Journal of Medicine|April 3, 1975
Severe combined immunodeficiency and adenosine deaminase deficiencyR Parkman, E W Gelfand, F S Rosen, et al.
The Journal of Clinical Investigation|March 1, 1976
Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulationsR Tung, R Silber, F Quagliata, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1984
Cell-cycle-specific cDNAs from mammalian cells temperature sensitive for growthR R Hirschhorn, P Aller, Z A Yuan, et al.
The Pediatric Infectious Disease Journal|June 1, 1994
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Moye, J Korelitz, et al.
Pageof 41